Compare Novavax Inc (NVAX) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs DENTSPLY SIRONA Inc — how do they compare? Novavax Inc trades at $7.96 (market cap $1.31B), while DENTSPLY SIRONA Inc trades at $11.69 (market cap $2.31B). The key difference: DENTSPLY SIRONA Inc is the larger of the two by market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | XRAY | |
|---|---|---|
Market Cap | $1.31B | $2.31B |
Sector | Health | Health |
52-Week High | $11.19 | $14.68 |
52-Week Low | $6.22 | $9.64 |
Enterprise Value | $889.30M | $4.39B |
Dividend Yield | — | 5.04% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
